Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs

Yoko Matsuda, Taro Yamashita, Juanjuan Ye, Mami Yasukawa, Keiko Yamakawa, Yuri Mukai, Mitsuhiro Machitani, Yataro Daigo, Yohei Miyagi, Tomoyuki Yokose, Takashi Oshima, Hiroyuki Ito, Soichiro Morinaga, Takeshi Kishida, Toshinari Minamoto, Shinji Yamada, Junko Takei, Mika K Kaneko, Motohiro Kojima, Shuichi Kaneko, Tsutomu Masaki, Masahiro Hirata, Reiji Haba, Keiichi Kontani, Nobuhiro Kanaji, Nobuyuki Miyatake, Keiichi Okano, Yukinari Kato, Kenkichi Masutomi

Open source

DOI
10.1002/path.5876
Published
2022-03-23
Container
The Journal of Pathology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/path.5876,
  title = {Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs},
  author = {Yoko Matsuda and Taro Yamashita and Juanjuan Ye and Mami Yasukawa and Keiko Yamakawa and Yuri Mukai and Mitsuhiro Machitani and Yataro Daigo and Yohei Miyagi and Tomoyuki Yokose and Takashi Oshima and Hiroyuki Ito and Soichiro Morinaga and Takeshi Kishida and Toshinari Minamoto and Shinji Yamada and Junko Takei and Mika K Kaneko and Motohiro Kojima and Shuichi Kaneko and Tsutomu Masaki and Masahiro Hirata and Reiji Haba and Keiichi Kontani and Nobuhiro Kanaji and Nobuyuki Miyatake and Keiichi Okano and Yukinari Kato and Kenkichi Masutomi},
  year = {2022},
  journal = {The Journal of Pathology},
  doi = {10.1002/path.5876},
  url = {https://doi.org/10.1002/path.5876}
}

RIS

TY  - JOUR
TI  - Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs
AU  - Yoko Matsuda
AU  - Taro Yamashita
AU  - Juanjuan Ye
AU  - Mami Yasukawa
AU  - Keiko Yamakawa
AU  - Yuri Mukai
AU  - Mitsuhiro Machitani
AU  - Yataro Daigo
AU  - Yohei Miyagi
AU  - Tomoyuki Yokose
AU  - Takashi Oshima
AU  - Hiroyuki Ito
AU  - Soichiro Morinaga
AU  - Takeshi Kishida
AU  - Toshinari Minamoto
AU  - Shinji Yamada
AU  - Junko Takei
AU  - Mika K Kaneko
AU  - Motohiro Kojima
AU  - Shuichi Kaneko
AU  - Tsutomu Masaki
AU  - Masahiro Hirata
AU  - Reiji Haba
AU  - Keiichi Kontani
AU  - Nobuhiro Kanaji
AU  - Nobuyuki Miyatake
AU  - Keiichi Okano
AU  - Yukinari Kato
AU  - Kenkichi Masutomi
PY  - 2022
JO  - The Journal of Pathology
DO  - 10.1002/path.5876
UR  - https://doi.org/10.1002/path.5876
ER  - 

APA

Matsuda, Y., Yamashita, T., Ye, J., Yasukawa, M., Yamakawa, K., Mukai, Y., Machitani, M., Daigo, Y., Miyagi, Y., Yokose, T., Oshima, T., Ito, H., Morinaga, S., Kishida, T., Minamoto, T., Yamada, S., Takei, J., Kaneko, M. K., Kojima, M., Kaneko, S., Masaki, T., Hirata, M., Haba, R., Kontani, K., Kanaji, N., Miyatake, N., Okano, K., Kato, Y., & Masutomi, K. (2022). Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs. The Journal of Pathology. https://doi.org/10.1002/path.5876

Source records